Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273].
No Thumbnail Available
Identifiers
Date
2021-12-02
Authors
Reck, M
Ciuleanu, T-E
Cobo, M
Schenker, M
Zurawski, B
Menezes, J
Richardet, E
Bennouna, J
Felip, E
Juan-Vidal, O
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
